Numinus | Revolutionary Therapy - Corporate Profile

April 13, 2021
Video
Numinus | Revolutionary Therapy - Corporate Profile

Numinus is an integrated mental health company creating an ecosystem of health solutions to research, develop, and deliver safe, evidence-based, accessible psychedelic-assisted psychotherapy.

28
Interviewed

Dr. Evan Wood

Chief Medical Officer
124

Company Mentioned

Numinus

127
Company Profile
Always do your own research and make your own investment decisions. This is not a solicitation to purchase or sell securities. Psychedelic Finance is not a registered investment advisor and does not purport to provide investment advice, whether implied or otherwise. Psychedelic Finance does not independently verify the accuracy or the truth of the statements or representations made by issuers. This message is meant for information and educational purposes only and Psychedelic Finance does not intend for this information to be used to inform an investment decision.
Features
News
Cognetivity Neurosciences Announces Collaboration with Alzheimer's Society to Further Expand its AI Algorithms
News
Filament Health Announces Interim Results From Phase I Clinical Trial At The University Of California San Francisco
News
Numinus to research COMP360 psilocybin therapy in treatment-resistant depression as part of large phase 3 study
News
MindMed Publishes Report by Leading FDA Experts Validating MindMed’s MM-120 Drug Development Strategy
© year Psychedelic Finance